Aignostics Secures $34 Million Series B to Enhance Precision ...

Aignostics secures $34M Series B to enhance precision medicine ...

In total, Aignostics has now raised over $55 million, reflecting investors' confidence in its differentiated AI models and clear commercial ...

Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced today that it ...

Aignostics secures $34 million Series B to improve precision ...

Aignostics. As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the ...

Aignostics Raises $34 Million in Series B | The SaaS News

Aignostics is an AI company focused on transforming complex pathology data into actionable insights for precision medicine. Leveraging ...

Aignostics Secures $34 Million Series B to Enhance Precision ...

Aignostics, a global artificial intelligence (AI) company announced today that it has raised $34 million in Series B financing.

News - Aignostics

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI · Bayer and Aignostics to collaborate on next generation precision oncology.

aignostics News & Press Releases | PR Newswire

... Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI. Aignostics, a global artificial intelligence (AI) company that ...

Aignostics secures 34 million US dollars in Series B - Startbase

Aignostics strengthens precision medicine through AI-based pathology models. The funds will be used for new products, US expansion and ...

Aignostics Secures $34 Million Series B To Enhance Precision ...

Aignostics Secures $34 Million Series B To Enhance Precision Medicine With AI · Launch of scaled "plug-and-play" products for a range of ...

Aignostics Secures $34M to Advance AI-Powered Pathology and ...

Aignostics raises $34 million to advance AI-powered pathology and precision medicine, developing new products, expanding its US presence...

Ascenion's portfolio company Aignostics secures $34 million Series ...

As precision medicine becomes more nuanced and complex, biopharmaceutical companies are increasingly turning to AI to enhance the utility, ...

Rainer Strohmenger on LinkedIn: Aignostics Secures $34 Million ...

Rainer Strohmenger's Post · Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI - Wellington · More from this author ...

Aignostics secures €31.4 million Series B to enhance precision ...

Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, ...

Aignostics Gains $34M Boosting AI-Driven Precision Medicine

Aignostics Raises $34M to Expand AI Pathology in the U.S.. Aignostics has raised $34 million in Series B funding, expanding AI-driven pathology ...

Invest In Aignostics Stock | Buy Pre-IPO Shares | EquityZen

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI. prnewswire • Oct 29, 2024. Bayer and Aignostics to collaborate on next ...

Aignostics raises $34M to transform precision medicine with AI

Aignostics has raised $34 million in Series B funding. With this, the total funding secured by the company to date accounts for $55 million.

Markets News - X

Aignostics secures $34 million in Series B funding for AI-driven precision medicine. The company plans to enhance its products, expand in ...

Series B - Aignostics - Crunchbase Funding Round Profile

Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI. News• Oct 29, 2024. aignostics.com — Aignostics secures $34M Series B to ...

Aignostics: Pioneering AI in Precision Medicine with $34 Million Boost

Aignostics, a Berlin-based artificial intelligence (AI) company, has secured $34 million in Series B funding ... AI to enhance their capabilities.

Aignostics Raises $34 Million Series B to Accelerate Precision ...

Aignostics, a global leader in AI-powered pathology, announced the close of a $34 million Series B funding round to expand product offerings ...